Novartis AG (BCBA:NVS)

Market Cap	302.95T
Revenue (ttm)	57.11T
Net Income (ttm)	13.80T
Shares Out	n/a
EPS (ttm)	6,842.86
PE Ratio	21.95
Forward PE	14.47
Dividend	624.65 (1.61%)
Ex-Dividend Date	Mar 12, 2025

Volume	186
Average Volume	178
Open	38,300
Previous Close	38,700
Day's Range	38,300 - 38,925
52-Week Range	26,525 - 40,500
Beta	n/a
RSI	70.27
Earnings Date	Jul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD